Pharma Journalist - Page 55 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

FDA Advises Sarepta to Lift Pause and Resume ELEVIDYS Shipments for Ambulatory Duchenne Patients

Boehringer Ingelheim and Re-Vana Partner to Develop Long-Acting Eye Disease Therapies

GSK and Hengrui Pharma Partner to Develop Up to 12 Innovative Medicines in Key Therapeutic Areas

FDA Approves SKYTROFA for Once-Weekly Adult Growth Hormone Deficiency Treatment

Gilead’s Twice-Yearly Lenacapavir Gets Positive CHMP Opinion for HIV Prevention

EU Regulators Back Alhemo Label Expansion for Haemophilia A and B Without Inhibitors

Pfizer and BioNTech COVID-19 Vaccine Adapted for LP.8.1 Variant Receives Positive CHMP Opinion in EU

Pfizer and 3SBio Finalize Licensing Deal

EU Approves Blenrep Combinations for Relapsed/Refractory Multiple Myeloma

Solid Biosciences Earns FDA Fast Track for SGT-501 Gene Therapy in CPVT